Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Izon Science granted core patents for elastomeric nanopore technology

Abstract:
Nanotechnology instrument manufacturer Izon Science today announced core patents for its nano and bio particle analysis platform. The United States Patent and Trademark Office (USPTO) has accepted Izon Science Patent No. 11/721047 for an invention for detecting, measuring and controlling particles. The patent covers the novel elastomeric size-tunable nanopores used in Izon Science's qNano and qViro instruments.

Izon Science granted core patents for elastomeric nanopore technology

Christchurch, New Zealand | Posted on June 9th, 2012

The Australian Patent Office has also accepted Izon Science Patent No. 2005315729 for the same core technology.

Izon Science has also been granted a patent for its analysis platform by the UK Intellectual Property Office. UK Patent No. 2477287 (formerly Application No. 1001311.8) for Control of particle flow in an aperture and relates to the use of combined pressure and voltage. This follows on from the prior award of the core patent in 2006 (GB2421303, 12 November 2006).

"Acceptance of these patents is a major milestone for the company. We're now selling our instrumentation in over 30 countries and are rapidly expanding our patent portfolio, core measurement capabilities and R&D capability," says Hans van der Voorn, Executive Chairman of Izon Science.

Van der Voorn says the company is experiencing high growth, in all areas where it operates. "We're now able to do R&D in our Boston and Oxford offices in addition to the work at our headquarters in Christchurch, New Zealand. By extending our R&D base we're able to work on more collaborative research which is very valuable for the company and its customers and research partners."

Izon Science is the developer of the portable qNano and qViro instruments with unique size-tunable nanopores. The multi-parameter instruments offer significant accuracy and reliability improvements over previously available techniques and are advancing research in a number of fields including nanomedicine, hematology, gene therapy and vaccine development.

####

About Izon Science
Izon Science has developed the world’s first nanopore based measurement system available for general use. Izon’s instruments are used for precise measurement and analysis of individual particles across a wide range of scientific fields including, nanomedicine, vaccinology, gene therapy and hematology. Izon originated in New Zealand and now sells its products in 30 countries. It has its European headquarters in Oxford, UK and US headquarters in Cambridge, MA.

For more information, please click here

Contacts:
Hans van der Voorn
Executive Chairman
Izon Science
Phone: + 64 21 463 399


Sandra Lukey
Shine Group
Phone: + 64 21 2262 858

Copyright © Izon Science

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Izon Science on Facebook:

Izon Science on Twitter:

Related News Press

News and information

Special UO microscope captures defects in nanotubes: University of Oregon chemists provide a detailed view of traps that disrupt energy flow, possibly pointing toward improved charge-carrying devices October 21st, 2014

Super stable garnet ceramics may be ideal for high-energy lithium batteries October 21st, 2014

Could I squeeze by you? Ames Laboratory scientists model molecular movement within narrow channels of mesoporous nanoparticles October 21st, 2014

Detecting Cancer Earlier is Goal of Rutgers-Developed Medical Imaging Technology: Rare earth nanocrystals and infrared light can reveal small cancerous tumors and cardiovascular lesions October 21st, 2014

Nanomedicine

Detecting Cancer Earlier is Goal of Rutgers-Developed Medical Imaging Technology: Rare earth nanocrystals and infrared light can reveal small cancerous tumors and cardiovascular lesions October 21st, 2014

Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons: At the Faculty of Pharmacy of the UPV/EHU-University of the Basque Country encapsulation techniques are being developed to deliver correctly and effectively certain drugs October 20th, 2014

Non-Toxic Nanocatalysts Open New Window for Significant Decrease in Reaction Process October 19th, 2014

European Commission opens the gate towards the implementation of Nanomedicine Translation Hub October 16th, 2014

Announcements

Special UO microscope captures defects in nanotubes: University of Oregon chemists provide a detailed view of traps that disrupt energy flow, possibly pointing toward improved charge-carrying devices October 21st, 2014

Super stable garnet ceramics may be ideal for high-energy lithium batteries October 21st, 2014

Could I squeeze by you? Ames Laboratory scientists model molecular movement within narrow channels of mesoporous nanoparticles October 21st, 2014

Detecting Cancer Earlier is Goal of Rutgers-Developed Medical Imaging Technology: Rare earth nanocrystals and infrared light can reveal small cancerous tumors and cardiovascular lesions October 21st, 2014

Tools

Special UO microscope captures defects in nanotubes: University of Oregon chemists provide a detailed view of traps that disrupt energy flow, possibly pointing toward improved charge-carrying devices October 21st, 2014

Super stable garnet ceramics may be ideal for high-energy lithium batteries October 21st, 2014

Detecting Cancer Earlier is Goal of Rutgers-Developed Medical Imaging Technology: Rare earth nanocrystals and infrared light can reveal small cancerous tumors and cardiovascular lesions October 21st, 2014

New Grand ARM Transmission Electron Microscope Offers Highest Commercially-Available Atomic Resolution of 63 Picometers October 17th, 2014

Patents/IP/Tech Transfer/Licensing

Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014

Aculon Receives Patent for Application of Enhanced Bonding Layers on Titanium October 9th, 2014

harmaEngine will join Nanobiotix’ pivotal trial for NBTXR3 in Soft Tissue Sarcoma to accelerate its development in Asia-Pacific: PharmaEngine to make milestone payment to Nanobiotix in October 2014 to recognize the value created October 8th, 2014

‘Small’ transformation yields big changes September 16th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE